companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

REGENERON PHARMACEUTICALS

SOUTH SALEM-USA

Company Name:
Corporate Name:
REGENERON PHARMACEUTICALS
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 777 Old Saw Mill River Road,SOUTH SALEM,NY,USA 
ZIP Code:
Postal Code:
10590 
Telephone Number: 9143457736 (+1-914-345-7736) 
Fax Number: 9143457735 (+1-914-345-7735) 
Website:
axokine. net, axokine. org, genexpharma. com, ihateregeneron. com, regenaron. com, regeneron. com, regener 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
591205 
USA SIC Description:
Pharmacies 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
GIBRALTAR MANAGEMENT CO.
PEQUOT CAPITAL
HUDSON OFFICE SUPPLY
Next company profile:
PEAK TECHNOLOGY
AMERICAN BOOKSELLERS ASSOCIATION
MARCEL;JOHN










Company News:
  • Regeneron | Pushing the Bounds of Science
    Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
  • Regeneron Pharmaceuticals - Wikipedia
    Regeneron Pharmaceuticals, Inc is an American biotechnology company headquartered in Westchester County, New York The company was founded in 1988 [2]
  • Dupixent® (dupilumab) Approved in the U. S. as the Only Targeted . . .
    This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc (“Regeneron” or the “Company”), and actual events or results may differ materially from these forward-looking statements Words such as “anticipate
  • Regeneron Announces New Investment in Manufacturing of its Industry . . .
    TARRYTOWN, N Y , April 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) today announced a significant expansion of its manufacturing capacity through a new agreement with FUJIFILM Diosynth Biotechnologies (“Fujifilm”) to manufacture and supply bulk drug product of Regeneron’s commercial biologic medicines at
  • Regeneron Pharmaceuticals, Inc. (REGN) Growth Story Shifts as Wells . . .
    On June 10, 2025, Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) received a ‘Hold’ rating from Wells Fargo, which set the company’s stock price target at $580 REGN is one of the 7 52-week
  • Clinical Trials Home | Regeneron Pharmaceuticals
    FIND A REGENERON CLINICAL TRIAL Be part of the discovery—explore Regeneron clinical trials as we work to translate science into medicine for people with serious diseases Find a relevant clinical trial near you
  • About Regeneron | Our Company - Regeneron Pharmaceuticals
    Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases
  • PUSH THE BOUNDS OF SCIENCE - Regeneron
    Regeneron is a leading biotechnology company dedicated to inventing, developing and commercializing life-transforming medicines for people with serious diseases Our mission is to use the power of science to bring new medicines to patients… over and over again
  • Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million
    Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday Regeneron said it will comply with 23andMe’s
  • Investor Relations | Regeneron Pharmaceuticals Inc.
    The Investor Relations website contains information about Regeneron Pharmaceuticals Inc 's business for stockholders, potential investors, and financial analysts




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer